These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 6423970)

  • 1. Immunogenicity of a synthetic HBsAg peptide: enhancement by conjugation to a fatty acid carrier.
    Hopp TP
    Mol Immunol; 1984 Jan; 21(1):13-6. PubMed ID: 6423970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibody response to two synthetic peptides corresponding to residues 45-68 and 69-79 of the major protein of hepatitis B surface antigen.
    Neurath AR; Kent SB; Strick N
    Virus Res; 1984; 1(4):321-31. PubMed ID: 6532005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune response to synthetic peptide analogues of hepatitis B surface antigen specific for the a determinant.
    Bhatnagar PK; Papas E; Blum HE; Milich DR; Nitecki D; Karels MJ; Vyas GN
    Proc Natl Acad Sci U S A; 1982 Jul; 79(14):4400-4. PubMed ID: 6181506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibodies to hepatitis B surface antigen (HBsAg) elicited by immunization with a synthetic peptide covalently linked to liposomes.
    Neurath AR; Kent SB; Strick N
    J Gen Virol; 1984 May; 65 ( Pt 5)():1009-14. PubMed ID: 6202827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthetic hepatitis B surface antigen peptide vaccine.
    Dreesman GR; Sparrow JT; Frenchick PJ; Kennedy RC
    Adv Exp Med Biol; 1985; 185():129-37. PubMed ID: 2416196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Appraisal and prospects of a dimeric synthetic peptide coupled with tetanus toxoid for a bifunctional vaccine against hepatitis B virus infection.
    Vyas GN; Bhatnagar PK; Blum HE; Expose J; Heldebrandt CM
    Dev Biol Stand; 1983; 54():93-102. PubMed ID: 6197328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancement of viral hepatitis B antibody (Anti-HBs) response to a synthetic cyclic peptide by priming with anti-idiotype antibodies.
    Kennedy RC; Sparrow JT; Sanchez Y; Melnick JL; Dreesman GR
    Virology; 1984 Jul; 136(1):247-52. PubMed ID: 6610985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunogenicity of conjugates and micelles of synthetic hepatitis B surface antigen peptides.
    Sanchez Y; Ionescu-Matiu II; Sparrow JT; Melnick JL; Dreesman GR
    Intervirology; 1982; 18(4):209-13. PubMed ID: 6183231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of immune responses to a native viral antigen and a synthetic peptide derived from it: implications for vaccine development.
    Kumar A; Kaul S; Manivel V; Rao KV
    Vaccine; 1992; 10(12):814-6. PubMed ID: 1280891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunity to hepatitis B: analysis of antibody and cellular responses in recipients of a plasma-derived vaccine using synthetic peptides mimicking S and pre-S regions.
    Steward MW; Sisley BM; Stanley C; Brown SE; Howard CR
    Clin Exp Immunol; 1988 Jan; 71(1):19-25. PubMed ID: 3349646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA-mediated immunization to the hepatitis B surface antigen. Activation and entrainment of the immune response.
    Whalen RG; Leclerc C; Dériaud E; Schirmbeck R; Reimann J; Davis HL
    Ann N Y Acad Sci; 1995 Nov; 772():64-76. PubMed ID: 8546414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemically synthesized peptides of hepatitis B surface antigen duplicate the d/y specificities and induce subtype-specific antibodies in chimpanzees.
    Gerin JL; Alexander H; Shih JW; Purcell RH; Dapolito G; Engle R; Green N; Sutcliffe JG; Shinnick TM; Lerner RA
    Proc Natl Acad Sci U S A; 1983 Apr; 80(8):2365-9. PubMed ID: 6188163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccine engineering: enhancement of immunogenicity of synthetic peptide vaccines related to hepatitis in chemically defined models consisting of T- and B-cell epitopes.
    Tam JP; Lu YA
    Proc Natl Acad Sci U S A; 1989 Dec; 86(23):9084-8. PubMed ID: 2480595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specificity of antibodies elicited by a synthetic peptide having a sequence in common with a fragment of a virus protein--the hepatitis B surface antigen.
    Neurath AR; Kent SB; Strick N
    Dev Biol Stand; 1983; 54():103-12. PubMed ID: 6197327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation and testing of a Haemophilus influenzae Type b/Hepatitis B surface antigen conjugate vaccine.
    An SJ; Woo JS; Chae MH; Kothari S; Carbis R
    Vaccine; 2015 Mar; 33(13):1614-9. PubMed ID: 25659268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutated epitopes of hepatitis B surface antigen fused to the core antigen of the virus induce antibodies that react with the native surface antigen.
    Shiau AL; Murray K
    J Med Virol; 1997 Mar; 51(3):159-66. PubMed ID: 9139078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specificity of antibodies elicited by a synthetic peptide having a sequence in common with a fragment of a virus protein, the hepatitis B surface antigen.
    Neurath AR; Kent SB; Strick N
    Proc Natl Acad Sci U S A; 1982 Dec; 79(24):7871-5. PubMed ID: 6185953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunochemical structure of the hepatitis B surface antigen vaccine--I. Treatment of immobilized HBsAg by dissociation agents with or without enzymatic digestion and identification of polypeptides by protein blotting.
    Pillot J; Petit MA
    Mol Immunol; 1984 Jan; 21(1):53-60. PubMed ID: 6423972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monoclonal antibodies to hepatitis B surface antigen (HBsAg) with anti-alpha specificity recognize a synthetic peptide analogue (S135-155) with unmodified lysine (141).
    Neurath AR; Kent SB; Strick N
    J Virol Methods; 1984 Dec; 9(4):341-6. PubMed ID: 6442302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunological evaluation of three generations of anti-idiotype vaccine: study of B and T cell responses following priming with anti-idiotype, anti-idiotype peptide and its MAP structure.
    Rajadhyaksha M; Yang YF; Thanavala YM
    Vaccine; 1995; 13(15):1421-6. PubMed ID: 8578819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.